microRNA as Therapeutic Target
This special issue belongs to the section "Cell and Gene Therapy".
Special Issue Information
Dear Colleagues,
It is known that miRNAs can play critical roles during disease progression. However, it is not frequent that they are treated as a therapeutic target. However, because of the advent of RNA drug discovery, more and more miRNAs are expected to be therapeutic targets. The submission of any kind of studies related to the identification of novel miRNAs as drug targets, the proposal of possible therapeutic targets of miRNAs, and experimental validations of therapeutic application of miRNA in vivo as well as in vitro, are welcome for this Special Issue.
Prof. Y-H. Taguchi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Epigenetic therapy
- RNA drug
- drug delivery
- exosome miRNA
- miRNA based therapy
- drug target miRNA
- miRNA based therapy
- RNA editing
- epitrancripotome
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Published Papers
Cells - ISSN 2073-4409